Skip to main content

Closed

APVO: Aptevo Therapeutics Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-166.3%

Financially safe

Stretched

Debt / equity0.38×

Interest coverage0.0×

Current ratio3.36×

Aptevo Therapeutics Inc.

APVONASDAQ Capital Market·USD·Closed

Aptevo Therapeutics Inc.

APVONASDAQ·USD·Closed

$4.11

−0.48%

$4.11

−$0.02 (0.48%)

52W Range

1thpctl

Volume

0.04×avg

Mkt Cap

8.99MUSD

P/E

-0.0TTM

Div Yield

–ann

52W Range

1thpctl

Volume

0.04×avg

Market Cap

8.99MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings